Shopping Cart 0
Cart Subtotal
USD 0

Oxford Nanopore Technologies Ltd - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Oxford Nanopore Technologies Ltd (Oxford Nanopore), formerly Oxford NanoLabs Ltd., develops disruptive, electronic, and single-molecule sensing system. The company's products include SmidgION, Flongle, MinION, PromethION and GridION used for the analysis of DNA, RNA, proteins, small molecules and other types of molecule. Its products find applications in various areas of research including microbiology, environmental research, microbiome, basic genome research, human genetics, cancer research, clinical research, plant research, transcriptome analysis, population genomics and animal research. The company also offers support, certification and training services. It works in partnership with various academic and industry research groups to launch new genomic and medical applications through its nanopore technology. Oxford Nanopore is headquartered in Oxford, Oxfordshire, the UK.

Oxford Nanopore Technologies Ltd-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Oxford Nanopore Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Oxford Nanopore Technologies Ltd, Medical Equipment, Deal Details 11

Venture Financing 11

Oxford Nanopore Raises USD 64 Million In Venture Financing 11

Oxford Nanopore Technologies Raises USD 50.8 Million In Venture Financing 13

Private Equity 14

Oxford Nanopore Tech Raises USD140 Million in Financing 14

Equity Offering 15

Oxford Nanopore Technologies Raises USD125.7 Million in Private Placement of Shares 15

Oxford Nanopore Raises USD109 Million in Private Placement of Shares 16

Oxford Nanopore Raises USD59 Million in Private Placement of Shares 17

Acquisition 18

Illumina Completes Sale Of 13.5% Stake In Oxford Nanopore For USD 91 Million 18

Oxford Nanopore Technologies Ltd-Key Competitors 19

Oxford Nanopore Technologies Ltd-Key Employees 20

Oxford Nanopore Technologies Ltd-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 22

Legal and Regulatory 22

May 09, 2018: Oxford Nanopore announces favourable outcome in UK and German patent litigation against Pacific Biosciences 22

Mar 22, 2018: Pacific Biosciences Prevails in Patent Eligibility Ruling Against Oxford Nanopore 23

Feb 08, 2018: Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore 24

Feb 08, 2018: Oxford Nanopore Successfully Defends PacBio lawsuit 25

Jan 22, 2018: Two new Oxford Nanopore Service providers: now cover US, China, Europe, Australia 26

Dec 10, 2017: Oxford Nanopore sequencing now available as a service: first two providers achieve certification 27

Sep 29, 2017: Response from Oxford Nanopore to new lawsuit from PacBio 28

Apr 21, 2017: Oxford Nanopore initiates legal proceedings against Pacific Biosciences 29

Mar 20, 2017: Oxford Nanopore responds to new, meritless lawsuit, delivered by PacBio one day after GridION launch 30

Feb 03, 2017: Response to UK Pacific Biosciences suit 31

Product News 32

May 10, 2018: New MinKNOW: software release makes nanopore sequencing better and easier 32

Apr 20, 2018: "Flu virus finally sequenced in its native form" using nanopore technology 33

Feb 23, 2018: PromethION in the wild: high yield data announcements in human and plant DNA 34

Feb 08, 2018: Pacific Biosciences Announces Outcome of First Phase of Patent Litigation Against Oxford Nanopore 35

Jan 29, 2018: Most complete human genome assembly to date: Nature Biotech paper uses Oxford Nanopore MinION 36

Dec 27, 2017: World first: continuous DNA sequence of more than a million bases achieved with nanopore sequencing 37

Nov 26, 2017: New applications posters released for Nanopore Community Meeting 38

Nov 16, 2017: One step closer to abolishing the cold chain: lyophilised kits for field-based sequencing 40

Oct 18, 2017: Oxford Nanopore at ASHG 2017 41

Oct 18, 2017: Oxford Nanopore RNA analysis: 7x less data and 50x fewer reads needed, very low GC bias 43

Oct 17, 2017: Oxford Nanopore starts developer programme to trial new enrichment methods for real time nanopore sequencing 44

Oct 12, 2017: China welcomes Oxford Nanopore technology 45

Sep 04, 2017: New basecaller now performs 'raw basecalling', for improved sequencing accuracy 46

Aug 17, 2017: Oxford Nanopore provides update on GridION X5 47

Jun 26, 2017: Oxford Nanopore launches cDNA analysis, for full length transcripts 48

May 09, 2017: 1D squared kit available in the store: boost accuracy, simple prep 49

Apr 24, 2017: Oxford Nanopore launches analysis workflow for antimicrobial resistance 50

Apr 19, 2017: Direct RNA sequencing with nanopore opens up to more users 51

Mar 14, 2017: Introducing GridION X5 52

Mar 14, 2017: Oxford Nanopore Technologies: Introducing GridION X5 53

Feb 16, 2017: MinION software (MinKNOW) upgraded to enable increased data yield, other benefits 54

Feb 16, 2017: Oxford Nanopore Technologies: Response to UK Pacific Biosciences suit 55

Other Significant Developments 56

Sep 18, 2018: KCCG installs their PromethION sequencer 56

Jul 02, 2018: GrandOmics becomes the first certified PromethION service provider in China 57

Apr 24, 2018: Nanopore service providers update: three new providers, and more 58

Jan 27, 2018: Oxford Nanopore Technologies: Sequence from as little as 10pg starting material 59

Appendix 60

Methodology 60

About GlobalData 60

Contact Us 60

Disclaimer 60


List Of Figure

List of Figures

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Oxford Nanopore Technologies Ltd, Medical Equipment, Key Facts 2

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Oxford Nanopore Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Oxford Nanopore Technologies Ltd, Deals By Market, 2012 to YTD 2018 9

Oxford Nanopore Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Oxford Nanopore Raises USD 64 Million In Venture Financing 11

Oxford Nanopore Technologies Raises USD 50.8 Million In Venture Financing 13

Oxford Nanopore Tech Raises USD140 Million in Financing 14

Oxford Nanopore Technologies Raises USD125.7 Million in Private Placement of Shares 15

Oxford Nanopore Raises USD109 Million in Private Placement of Shares 16

Oxford Nanopore Raises USD59 Million in Private Placement of Shares 17

Illumina Completes Sale Of 13.5% Stake In Oxford Nanopore For USD 91 Million 18

Oxford Nanopore Technologies Ltd, Key Competitors 19

Oxford Nanopore Technologies Ltd, Key Employees 20

Oxford Nanopore Technologies Ltd, Other Locations 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Oxford Nanopore Technologies Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.